• About us
• Contact

Advertisement

Organisation › Details

Bayern Kapital Risikokapitalbeteiligungs GmbH

Bayern Kapital GmbH, based in Landshut (Germany), is the venture/growth capital company of the Free State of Bavaria. It supports innovative high-tech companies in Bavaria through their various growth phases, from seed to later stage, with equity capital from EUR 0.25 to 25 million. Bayern Kapital often closes gaps in the VC area in proven consortium arrangements with private investors (business angels, family offices and corporate ventures). Bayern Kapital manages specialist investment funds with a volume of around EUR 700 million. Since its formation in 1995 at the initiative of the state government, the wholly-owned subsidiary of LfA Foerderbank Bayern has invested around EUR 400 million of its own equity capital so far in around 300 start-ups and scale-ups from industries such as life sciences, software & IT, materials & new materials, nanotechnology and environmental technology. More than 8,000 long-term jobs in sustainable companies have been created in Bavaria. The active portfolio currently comprises around 80 companies. Examples of the many ground-breaking success stories that Bayern Kapital has already supported at an early stage include EOS (now the world’s leading technology provider in industrial 3D printing of metals and plastics), Proglove, Fazua, SimScale, Scompler, egym, Parcellab, Cobrainer, Quantum Systems, Casavi, Theva, Riskmethods, Tubulis, Catalym, Immunic, Sirion, tado and many more. *

 

	Start	1995-12-01 established
	Group	Bavaria (govt region)
	Industry	venture capital
	Person	Ried, Georg (Bavaria (govt) 201607 Managing Director of Bayern Kapital)
	Person 2	Linseis, Brigitte (Bavaria (govt) 201402 Senior Investment Manager at Bayern Kapital)
	Region	Landshut
	Country	Germany
	Street	135 a Ländgasse
	City	84028 Landshut
	Tel	0871-92325-0
		Address record changed: 2024-05-08
Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	700,000,000 (capital under management (2023) 2023-03-23)
		* Document for »About Section«: Mbiomics GmbH. (3/23/23). "Press Release: Microbiome Therapeutics Biotech Mbiomics Raises EUR 13 Million in First Closing of Series A Round". Munich.
		Record changed: 2024-05-08

Advertisement

More documents for Bavaria (govt region)

• [1] IZB Martinsried. (3/8/24). "Press Release: Christian Gnam Succeeds Dr. Peter Zobel as New Managing Director of the Biotechnology Innovation and Start-up Center (IZB)". Martinsried....
• [2] Novogene. (12/8/23). "Press Release: Novogene Expands Its European Operations with New Genomics Facility at the IZB in Munich, Germany". Martinsried....
• [3] IZB Martinsried. (7/25/23). "Press Release: Viopas Venture Consulting Opens Office in the Innovation and Start-up Center Biotechnology (IZB)". Martinsried....
• [4] BioM Biotech Cluster Development GmbH. (Juli 2023). Cluster Biotechnology Bavaria – Report 2022/23. Martinsried. [http://www.bio-m.org, 07/26/23]...
• [5] BioM Biotech Cluster Development GmbH. (12/12/22). "Press Release: Martinsried Gets Start-up Incubator Munich Accelerator Life Sciences & Medicine (MAxL)". Martinsried....
• [6] BioM Biotech Cluster Development GmbH. (10/12/22). "Press Release: Osaka and Munich Continue Their Cuccessful Partnership"....
• [7] IZB Martinsried. (10/7/22). "Press Release: Munich Life Science Pitch Day at the IZB. Eleven Teams Presented to 28 Life Science Investors with an Available Investment Volume of more than 20 Billion Euros". Martinsried....
• [8] BioM Biotech Cluster Development GmbH. (9/30/22). "Press Release: Prof. Ralf Huss Appointed as New Managing Director of BioM Biotech Cluster Development GmbH"....
• [9] IZB Martinsried. (7/14/22). "Press Release: Cutting-edge Research at Munich’s IZB Attracts Strong Interest". Martinsried....
• [10] Max Planck Society. (4/29/21). "Press Release: Top Address for Life Science Research. Bavaria Invests up to 500 Million Euros in the Competitive Development of the Martinsried Max Planck Campus into an Outstanding International Research Hub"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.